Revenue (Quarterly) Chart

View Revenue (Quarterly) for A.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Quarterly) Chart
Start Trial

Historical Revenue (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
April 30, 2026 1.835B
January 31, 2026 1.798B
October 31, 2025 1.861B
July 31, 2025 1.738B
April 30, 2025 1.668B
January 31, 2025 1.681B
October 31, 2024 1.701B
July 31, 2024 1.578B
April 30, 2024 1.573B
January 31, 2024 1.658B
October 31, 2023 1.688B
July 31, 2023 1.672B
April 30, 2023 1.717B
January 31, 2023 1.756B
October 31, 2022 1.849B
July 31, 2022 1.718B
April 30, 2022 1.607B
January 31, 2022 1.674B
October 31, 2021 1.66B
July 31, 2021 1.586B
April 30, 2021 1.525B
January 31, 2021 1.548B
October 31, 2020 1.483B
July 31, 2020 1.261B
April 30, 2020 1.238B
Date Value
January 31, 2020 1.357B
October 31, 2019 1.367B
July 31, 2019 1.274B
April 30, 2019 1.238B
January 31, 2019 1.284B
October 31, 2018 1.294B
July 31, 2018 1.203B
April 30, 2018 1.206B
January 31, 2018 1.211B
October 31, 2017 1.189B
July 31, 2017 1.114B
April 30, 2017 1.102B
January 31, 2017 1.067B
October 31, 2016 1.111B
July 31, 2016 1.044B
April 30, 2016 1.019B
January 31, 2016 1.028B
October 31, 2015 1.035B
July 31, 2015 1.014B
April 30, 2015 963.00M
January 31, 2015 1.026B
October 31, 2014 1.043B
July 31, 2014 1.009B
April 30, 2014 1.731B
January 31, 2014 1.679B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Danaher Corp. 6.265B
Thermo Fisher Scientific, Inc. 11.99B
Waters Corp. --
Illumina, Inc. 1.161B
Revvity, Inc. 729.69M